Sponsor pipeline

Bayer clinical trial pipeline

Get alerts when Bayer's trials change

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

21 trials changed in the last 30 days: 0 stopped, 4 with notable changes, 17 with minor changes only.

Notable

United States to Learn How Venous Thromboembolism, Disseminated Intravascular Coagulation, and Sepsis Are Related

Primary and study completion pushed from Aug 31, 2026 to Apr 30, 2027

BayerNot specified NCT06765681 Registry history of NCT06765681 on ClinicalTrials.gov (opens the registry)

Oct 19, 2026
Notable

Safe the Study Treatment Actinium-225-macropa-pelgifatamab (BAY3546828) is, How it Affects the Body, How it Moves Into, Through and Out of the Body, and About Its Anticancer Activity · Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)

Enrollment reduced: 232 → 85 participants

Also in this update: Trial sites reduced: 17 → 11 locations; and 1 more change in the last 30 days

BayerPhase 1 NCT06052306 Registry history of NCT06052306 on ClinicalTrials.gov (opens the registry)

Oct 16, 2026
Notable

ROAD · Men With Advanced Prostate Cancer Respond to Treatment With Darolutamide and Hormone Therapy, With or Without Chemotherapy, in Real-world Medical Practice

Enrollment reopened

BayerNot specified NCT07344779 Registry history of NCT07344779 on ClinicalTrials.gov (opens the registry)

Oct 19, 2026
Notable

RELIEF · How Elinzanetant is Used and How Well it Works · Menopause Symptoms in United States

Enrollment increased: 1500 → 2400 participants

BayerNot specified NCT07490431 Registry history of NCT07490431 on ClinicalTrials.gov (opens the registry)

Sep 24, 2026

Show 17 trials with minor changes only

Minor

How a New Nurandociguat Tablet is Absorbed and Processed in the Body Compared to an Old Tablet and How Food Affects the Way the New Tablet is Absorbed and Processed in the Body

Trial completed

Also in this update: Final enrollment: 16 participants (planned 18)

BayerPhase 1 NCT07722585 Registry history of NCT07722585 on ClinicalTrials.gov (opens the registry)

Oct 19, 2026
Minor

SHIELD-ET · Mirena and Other Progestogen Treatments Are Used for Endometrial Protection in Women 40+ With a Uterus in the United States Receiving Estrogen Therapy, and Their Respective Health Outcomes

Trial status changed: Not Yet Recruiting → Active, Not Recruiting

BayerNot specified NCT07795606 Registry history of NCT07795606 on ClinicalTrials.gov (opens the registry)

Oct 19, 2026
Minor

How Well · Severe Hemophilia A Respond to Treatment With BAY 2599023 (DTX 201), a Drug Therapy That Delivers a Healthy Version of the Defective Factor VIII Gene Into the Nucleus of Liver Cells Using an Altered, Non-infectious Virus (AAV) as a "Shuttle

Trial completed

BayerPhase 1/2 NCT03588299 Registry history of NCT03588299 on ClinicalTrials.gov (opens the registry)

Sep 23, 2026
Minor

Called FINE-REAL Korea to Learn More About the Use of the Drug Finerenone · Chronic Kidney Disease and Type 2 Diabetes in a Routine Medical Care Setting in South Korea

Enrollment closed, study ongoing

BayerNot specified NCT07232537 Registry history of NCT07232537 on ClinicalTrials.gov (opens the registry)

Oct 8, 2026
Minor

RE-ENGAGE · Treatment Patterns and Factors Determining the Choice of Treatment in Canadian · Metastatic Hormone Sensitive Prostate Cancer in Routine Medical Care

Trial completed

Also in this update: Primary completion date changed from estimate of Dec 31, 2026 to Jun 30, 2026; Final enrollment: 477 participants (planned 700)

BayerNot specified NCT06874114 Registry history of NCT06874114 on ClinicalTrials.gov (opens the registry)

Oct 6, 2026
Minor

22663 · How Safe Finerenone is and How Well it Works · Chronic Kidney Disease and Type 2 Diabetes in Routine Medical Care in the United States

Trial completed

Also in this update: Final enrollment: 238038 participants (planned 150000)

BayerNot specified NCT06608212 Registry history of NCT06608212 on ClinicalTrials.gov (opens the registry)

Sep 24, 2026
Minor

FINEXPLORER · Called FINEXPLORER, to Learn More About How Well Finerenone Works in Adults in Spain With Chronic Kidney Disease (CKD) Linked to Type 2 Diabetes, by Looking at Changes in a CKD Risk Score

Primary and study completion pushed from Apr 30, 2029 to May 31, 2029

BayerNot specified NCT07554469 Registry history of NCT07554469 on ClinicalTrials.gov (opens the registry)

Oct 14, 2026
Minor

IN-REALITY · How Safe Finerenone is and How Well it Works in Indian · Chronic Kidney Disease and Type 2 Diabetes in Routine Medical Practice

Primary and study completion pushed from Sep 30, 2026 to Oct 31, 2026

BayerNot specified NCT06763146 Registry history of NCT06763146 on ClinicalTrials.gov (opens the registry)

Oct 14, 2026
Minor

SOHO-02 · How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, · Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

Enrollment reduced: 555 → 444 participants

And 1 more change in the last 30 days

BayerPhase 3 NCT06452277 Registry history of NCT06452277 on ClinicalTrials.gov (opens the registry)

Oct 15, 2026
Minor

How Safe BAY3389934 is and How it Affects Blood Clotting When Given Alone or With Aspirin in Healthy Participants

Primary and study completion pushed from Nov 11, 2026 to Dec 29, 2026

BayerPhase 1 NCT07652723 Registry history of NCT07652723 on ClinicalTrials.gov (opens the registry)

Sep 23, 2026
Minor

ACO-MONITOR · Acceptance and Feasibility of a Digital Remote Monitoring Tool Configured · ATTR-CM: ACO-Monitor

Primary completion pushed from Feb 28, 2028 to Apr 15, 2028

Also in this update: Study completion pushed from Mar 28, 2028 to May 15, 2028

BayerNot specified NCT07557147 Registry history of NCT07557147 on ClinicalTrials.gov (opens the registry)

Sep 24, 2026
Minor

Methodological Study to Learn More About Kidney Function in Healthy People and · Reduced Kidney Function

Enrollment increased: 50 → 58 participants

BayerNot applicable NCT07368712 Registry history of NCT07368712 on ClinicalTrials.gov (opens the registry)

Oct 14, 2026
Minor

PACE mHSPC · Darolutamide Plus Androgen Deprivation Therapy · Metastatic Hormone-sensitive Prostate Cancer in India

Enrollment increased: 50 → 60 participants

Also in this update: Start date pushed from Oct 5, 2026 to Oct 15, 2026

BayerNot specified NCT07806591 Registry history of NCT07806591 on ClinicalTrials.gov (opens the registry)

Oct 6, 2026
Minor

ACO-REAL · Use of Acoramidis · a Heart Condition Called Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in a Real-world Setting

Trial sites expanded: 1 → 17 locations

Also in this update: Study completion moved earlier from Jul 3, 2028 to Apr 30, 2028

BayerNot specified NCT07235462 Registry history of NCT07235462 on ClinicalTrials.gov (opens the registry)

Oct 8, 2026
Minor

Called FINE-REAL to Learn More About the Use of the Drug Finerenone in a Routine Medical Care Setting

Primary completion date changed from estimate of Nov 5, 2026 to Sep 28, 2026

BayerNot specified NCT05348733 Registry history of NCT05348733 on ClinicalTrials.gov (opens the registry)

Oct 16, 2026
Minor

PATENT-CHILD · Riociguat · Pulmonary Arterial Hypertension (PAH)

Study completion pushed from Aug 3, 2027 to May 15, 2028

BayerPhase 3 NCT02562235 Registry history of NCT02562235 on ClinicalTrials.gov (opens the registry)

Sep 23, 2026
Minor

CARDIOVERT · How Well BAY 3670549 Works and How Safe it is · Atrial Fibrillation

Start date pushed from Aug 18, 2026 to Sep 1, 2026

BayerPhase 2 NCT07625215 Registry history of NCT07625215 on ClinicalTrials.gov (opens the registry)

Oct 6, 2026

Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.

New trial filings, last 30 days

First posted	Trial	Phase	Status
2026-09-25	NCT07841015 A Study to Learn More About How Well Finerenone Works in Real-World in People With Type 2…		Not Yet Recruiting

Active trials by phase

Phase 1		12
Phase 1/2		3
Phase 2		6
Phase 3		10
Phase 4		3

Not charted: 52 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials, top 10 of 33

Prostate Cancer (17) · Heart Disease (11) · Chronic Kidney Disease (8) · Heart Failure (7) · Diabetes (6) · Hemophilia (6) · Type 2 Diabetes (6) · Lung Cancer (5) · Non-Small Cell Lung Cancer (NSCLC) (5) · Amyloidosis (4)

Get alerts when Bayer's trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.

Start monitoring free